Exact Sciences Corporation (EXAS)

Chart for EXAS

Over the next 13 weeks, Exact Sciences Corporation has on average historically risen by 9.9% based on the past 16 years of stock performance.

Exact Sciences Corporation has risen higher by an average 9.9% in 8 of those 16 years over the subsequent 13 week period,corresponding to a historical probability of 50%

The holding period that leads to the greatest annualized return for Exact Sciences Corporation, based on historical prices, is 3 weeks. Should Exact Sciences Corporation stock move in the future similarly to its average historical movement over this duration, an annualized return of 176% could result.

Medicines Co. (MDCO)

Chart for MDCO

Over the next 13 weeks, Medicines Co. has on average historically risen by 5.2% based on the past 16 years of stock performance.

Medicines Co. has risen higher by an average 5.2% in 8 of those 16 years over the subsequent 13 week period,corresponding to a historical probability of 50%

The holding period that leads to the greatest annualized return for Medicines Co., based on historical prices, is 5 weeks. Should Medicines Co. stock move in the future similarly to its average historical movement over this duration, an annualized return of 41% could result.

U.S. Silica Holdings, Inc. (SLCA)

Chart for SLCA

Over the next 13 weeks, U.S. Silica Holdings, Inc. has on average historically risen by 9.6% based on the past 5 years of stock performance.

U.S. Silica Holdings, Inc. has risen higher by an average 9.6% in 4 of those 5 years over the subsequent 13 week period,corresponding to a historical probability of 80%

The holding period that leads to the greatest annualized return for U.S. Silica Holdings, Inc., based on historical prices, is 1 week. Should U.S. Silica Holdings, Inc. stock move in the future similarly to its average historical movement over this duration, an annualized return of 110% could result.

Supernus Pharmaceuticals, Inc. (SUPN)

Chart for SUPN

Over the next 13 weeks, Supernus Pharmaceuticals, Inc. has on average historically risen by 27.1% based on the past 5 years of stock performance.

Supernus Pharmaceuticals, Inc. has risen higher by an average 27.1% in 5 of those 5 years over the subsequent 13 week period,corresponding to a historical probability of 100%

The holding period that leads to the greatest annualized return for Supernus Pharmaceuticals, Inc., based on historical prices, is 6 weeks. Should Supernus Pharmaceuticals, Inc. stock move in the future similarly to its average historical movement over this duration, an annualized return of 270% could result.